Search Within

Jaclyn Frances Hechtman

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Meeting Abstract (65)
  2. Journal Article (63)
  3. Review (2)
  4. Book Section (1)
  5. Guidelines (1)
  6. Research Letter (1)
Groups
  1. GSK Faculty (133)
  2. Human Oncology and Pathogenesis Program (133)
  3. Department of Pathology and Laboratory Medicine (125)
  4. Department of Medicine (112)
  5. Solid Tumor Oncology Division (112)
  6. Center for Molecular Imaging and Biotechnology (CMIB) (90)

More Groups

People
  1. Marc Ladanyi (69)
  2. Michael Berger (66)
  3. David Solit (52)
  4. Ahmet Zehir (50)
  5. Nikolaus Schultz (47)
  6. Jinru Shia (46)

More People

Years
  1. 2025 (1)
  2. 2024 (2)
  3. 2023 (3)
  4. 2022 (1)
  5. 2021 (10)
  6. 2020 (15)

More Years

Publications
  1. Journal of Clinical Oncology (29)
  2. Modern Pathology (16)
  3. Clinical Cancer Research (12)
  4. Laboratory Investigation (11)
  5. Journal of Molecular Diagnostics (10)
  6. Annals of Oncology (7)

More Publications

Publishers
  1. American Society of Clinical Oncology (34)
  2. American Association for Cancer Research (25)
  3. Nature Publishing Group (17)
  4. Nature Research (16)
  5. Elsevier Science, Inc. (11)
  6. Oxford University Press (8)

More Publishers

Results (133)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Next-generation sequencing (NGS) in advanced well differentiated pancreatic neuroendocrine tumors (WD pNETs): A study using MSK-IMPACT
    Meeting Abstract

    Raj, N. P.; Soumerai, T.; Valentino, E.; Hechtman, J. F.; Berger, M. F.; Reidy, D. L.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Genomic profiling and efficacy of anti-EGFR therapy in appendiceal adenocarcinoma
    Meeting Abstract

    Braghiroli, M.; Nash, G. M.; Morris, M.; Hechtman, J. F.; Vakiani, E.; Berger, M. F.; Solit, D. B.; Saltz, L.; Cercek, A.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Reliable detection of mismatch repair deficiency in colorectal cancers using mutational load in next-generation sequencing panels
    Journal Article

    Stadler, Z. K.; Battaglin, F.; Middha, S.; Hechtman, J. F.; Tran, C.; Cercek, A.; Yaeger, R.; Segal, N. H.; Varghese, A. M.; Reidy-Lagunes, D. L.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • A novel crizotinib-resistant solvent-front mutation responsive to cabozantinib therapy in a patient with ROS1-rearranged lung cancer
    Journal Article

    Drilon, A.; Somwar, R.; Wagner, J. P.; Vellore, N. A.; Eide, C. A.; Zabriskie, M. S.; Arcila, M. E.; Hechtman, J. F.; Wang, L.; Smith, R. S.; more...
    Clinical Cancer Research (2016)

    Fulltext@MSK | Save
  • What hides behind the MASC: Clinical response and acquired resistance to entrectinib after ETV6-NTRK3 identification in a mammary analogue secretory carcinoma (MASC)
    Journal Article

    Drilon, A.; Li, G.; Dogan, S.; Gounder, M.; Shen, R.; Arcila, M.; Wang, L.; Hyman, D. M.; Hechtman, J.; Wei, G.; more...
    Annals of Oncology (2016)

    Fulltext@MSK | Save
  • Identification of targetable kinase alterations in patients with colorectal carcinoma that are preferentially associated with wild-type RAS/RAF
    Journal Article

    Hechtman, J. F.; Zehir, A.; Yaeger, R.; Wang, L.; Middha, S.; Zheng, T.; Hyman, D. M.; Solit, D.; Arcila, M. E.; Borsu, L.; more...
    Molecular Cancer Research (2016)

    Fulltext@MSK | Save
  • Recurrent, truncating SOX9 mutations are associated with KRAS and PI3K pathway mutations and may be oncogenic in colorectal carcinoma
    Meeting Abstract

    Hechtman, J.; Javier, B. M.; Vakiani, E.; Shia, J.; Zehir, A.; Iacobuzio-Donahue, C.
    Modern Pathology (2016)

    Fulltext@MSK | Save
  • 20q gain is an oncogenic driver event that occurs preferentially in KRAS/ BRAF wild type colorectal carcinoma
    Meeting Abstract

    Pagan, C.; Ptashkin, R.; Zehir, A.; Berger, M. F.; Shia, J. R.; Vakiani, E.; Ladanyi, M.; Hechtman, J.
    Modern Pathology (2016)

    Fulltext@MSK | Save
  • Comprehensive morphological assessment of colorectal cancers characterized by The Cancer Genome Atlas (TCGA) identifies specific morphology-molecular alteration associations
    Meeting Abstract

    Shia, J. R.; Kuk, D.; Schultz, N.; Berger, M.; Middha, S.; Vakiani, E.; Hechtman, J.; Stadler, Z.; Weiser, M.; Gonen, M.; more...
    Modern Pathology (2016)

    Fulltext@MSK | Save
  • 20q gain is an oncogenic driver event that occurs preferentially in KRAS/BRAF wild type colorectal carcinoma
    Meeting Abstract

    Pagan, C.; Ptashkin, R.; Zehir, A.; Berger, M. F.; Shia, J.; Vakiani, E.; Ladanyi, M.; Hechtman, J.
    Laboratory Investigation (2016)

    Fulltext@MSK | Save